A05218 - Designates an individual to be notified in the case of dose or brand change for psychotropic medication.
New York - 2023-2024 General Assembly
Introduced byWilliam A. Barclay, Brian Manktelow, John L. Lemondes
Last updated over 1 year ago
6 Co-Sponsors
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now